Reducing mortality from 2019-nCoV: host-directed therapies should be an option

Category: Current treatment experience

Preprint: Peer-reviewed

Tags: antiviral, cyclosporine, kaletra, lopinavir/ritonavir, monoclonal antibodies, Remdesivir, Tocilizumab, and treatment

Source: The Lancet

Source link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30305-6/fulltext

Date of publication: 02/05/2020

Added: 03/04/2020 20:45

Download PDF

2020.02.05-The-Lancet-Reducing-mortality-from-2019-nCoV-host-directed-therapies-should-be-an-option